AmeriCann, Inc. (OTCQB: ACAN), an Agricultural-Technology company that is developing state-of-the-art greenhouse cannabis cultivation and processing properties, announced today that CEO Tim Keogh will be speaking at the Cannabis Community Care and Research Network’s (C3RN) Cannabis Science and Education Series on Sunday, September 23 in Boston, MA.
The event is part of C3RN’s monthly Cannabis Science, Education, and Networking series in Massachusetts to showcase the latest cannabis innovations. The events attract diverse groups of leaders from within and outside of the cannabis industry, public health and policy experts and other businesses. Mr. Keogh will be leading a discussion about best practices for cannabis cultivation and extraction.
Tim Keogh, AmeriCann CEO, has spoken at cannabis industry conferences across the United States as an expert on topics including industry best practices, real estate development and the cannabis economy. Marijuana Business Daily recognized Mr. Keogh as one of the “Top People to Watch in 2018.”
AmeriCann is developing the Massachusetts Medical Cannabis Center (MMCC), a state-of-the-art cannabis cultivation and processing development in the midst of the rapidly growing Massachusetts medical cannabis market. The MMCC project is approved for 1 million square feet, which will be developed in phases and is expected to be one of the most technologically advanced cultivation facilities in the nation.
On September 25, 2018, AmeriCann will host a ground-breaking celebration at the MMCC in Freetown at 11am. The event will celebrate the first phase of the MMCC construction which will be a 30,000 sq. ft. cannabis cultivation, processing and research facility. AmeriCann plans to complete the first phase of the MMCC by the spring of 2019.